Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Optimal treatment of stage III NSCLC

Which systemic therapy in concurrent chemoradiotherapy?


07 Oct 2016


Optimal treatment of stage III NSCLC


Johan Vansteenkiste


J.F. Vansteenkiste

Author affiliations

  • Respiratory Oncology Unit - Department Respiratory Diseases, University Hospitals KU Leuven, 3000 - Leuven/BE


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings